XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
At The Market Offering
Common Stock
At The Market Offering
Additional Paid-in Capital
At The Market Offering
Equity Line Financing
Common Stock
Equity Line Financing
Additional Paid-in Capital
Equity Line Financing
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balances at Dec. 31, 2022             $ 29 $ 155,820 $ (115,401) $ (199) $ 40,249
Beginning Balances (in shares) at Dec. 31, 2022             28,991,548        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     0
Equity-based compensation               1,187     $ 1,187
Issuance of common stock   $ 197 $ 197   $ 318 $ 318          
Issuance of common stock (in shares) 95,823     189,856              
Other comprehensive gain (loss)                   4 4
Net loss                 (6,172)   (6,172)
Ending Balances at Mar. 31, 2023             $ 29 157,522 (121,573) (195) 35,783
Ending Balances (in shares) at Mar. 31, 2023             29,277,227        
Beginning Balances at Dec. 31, 2023             $ 32 165,826 (141,189) (195) $ 24,474
Beginning Balances (in shares) at Dec. 31, 2023             32,165,478        
Shareholders' Equity                      
Exercise of common stock options (in shares)                     0
Equity-based compensation               1,171     $ 1,171
Reclassification adjustment of foreign currency translation included in net loss for liquidation of subsidiary                   $ 195 195
Issuance of common stock $ 8 $ 11,888 $ 11,896   $ 381 $ 381          
Issuance of common stock (in shares) 7,557,142     191,273              
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes               (106)     (106)
Issuance of common stock upon vesting of RSUs, net of shares withheld for employee taxes (in shares)             71,973        
Net loss                 (9,151)   (9,151)
Ending Balances at Mar. 31, 2024             $ 40 $ 179,160 $ (150,340)   $ 28,860
Ending Balances (in shares) at Mar. 31, 2024             39,985,866